Overstimulation of the ergoreflex-A possible mechanism to explain symptoms in long COVID.
breathlessness
ergoreflex
fatigue
heart failure
long COVID
pathophyisology
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
05
2022
accepted:
28
06
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
2
8
2022
Statut:
epublish
Résumé
Long COVID refers to a multitude of symptoms that persist long after SARS-CoV-2 infection. Fatigue and breathlessness are the most common symptoms of long COVID across a range of studies. They are also cardinal symptoms of chronic heart failure (CHF). In this review, we propose that fatigue and breathlessness in patients with long COVID may be explained by skeletal muscle abnormalities, in a manner similar to patients with CHF. The ergoreflex is a cardiorespiratory reflex activated by exercise, which couples ventilation and cardiovascular function to exercise intensity. At least part of the symptomatology of CHF is related to abnormal skeletal muscle and an enhanced ergoreflex, resulting in heightened sympathetic, vasoconstrictor and ventilator drives. Similarly, SARS-CoV-2 infection results in a hyperinflammatory and hypercatabolic state. This leads to reduction in skeletal muscle mass and altered function. We postulate that the ergoreflex is chronically overstimulated, resulting in fatigue and breathlessness. Exercise training preserves muscle mass and function as well as reduces ergoreflex activation; therefore may have a role in improving symptoms associated with long COVID. Should the ergoreflex be proven to be an important pathophysiological mechanism of long COVID, tailored exercise interventions should be trialed with the aim of improving both symptoms and perhaps outcomes in patients with long COVID.
Identifiants
pubmed: 35911550
doi: 10.3389/fcvm.2022.940832
pmc: PMC9334659
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
940832Informations de copyright
Copyright © 2022 Sze, Pan, Moss, Ong, Pareek, Squire and Clark.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Microbiol Infect. 2022 Jul;28(7):955-972
pubmed: 35182760
Signal Transduct Target Ther. 2021 Dec 16;6(1):427
pubmed: 34916489
Eur J Heart Fail. 2021 Sep;23(9):1458-1467
pubmed: 34268843
Viruses. 2021 Apr 18;13(4):
pubmed: 33919537
ESC Heart Fail. 2017 Nov;4(4):492-498
pubmed: 29154428
Clin Nutr. 2021 Apr;40(4):2420-2426
pubmed: 33160700
Lancet Respir Med. 2022 Aug;10(8):761-775
pubmed: 35472304
Nat Metab. 2020 Jul;2(7):572-585
pubmed: 32694793
J Physiol. 1937 Jun 3;89(4):372-83
pubmed: 16994867
Heart. 2006 Jan;92(1):12-6
pubmed: 16159969
Nature. 2021 Nov;599(7886):546-548
pubmed: 34815580
Diagn Pathol. 2021 Apr 13;16(1):31
pubmed: 33849598
FEBS J. 2020 Sep;287(17):3681-3688
pubmed: 32779891
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102167
pubmed: 34186344
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Endocrine. 2022 Feb;75(2):317-327
pubmed: 35043384
Circulation. 1996 Mar 1;93(5):940-52
pubmed: 8598085
Prim Care Diabetes. 2021 Aug;15(4):629-634
pubmed: 33849817
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):905-919
pubmed: 33389262
J Clin Med. 2022 Jan 20;11(3):
pubmed: 35159974
Front Physiol. 2021 Mar 11;12:640973
pubmed: 33776796
BMC Infect Dis. 2021 Aug 21;21(1):855
pubmed: 34418980
Lancet Respir Med. 2021 Nov;9(11):1275-1287
pubmed: 34627560